ViroCyt Inc.
Industry
- Biotechnology
- Large Molecule
- Gene Therapy, Cell Therapy
- Pharmaceuticals
- Vaccines
- Research, Analytical Equipment & Supplies
See more in Biomedtracker
Latest on ViroCyt Inc.
In Vivo
• By Amanda Micklus and Maureen Riordan
Device Transactions Financing by device companies in the first quarter of 2017 totaled $2.3 billion, slightly lower than Q4 2016's $2.4 billion. Notably, early-stage venture capital fundraising made u
In Vivo
IN VITRO DIAGNOSTICS Alliances Cleveland HeartLab LLC Global Discovery Biosciences Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS ( Prote
Scrip
IN VITRO DIAGNOSTICS 23andMe Inc. 23andMe completes $150mm Series E financing 23andMe Inc. , which sells DNA testing kits directly to consumers who contribute their data to large-scale genetic